Reaction Details |
| Report a problem with these data |
Target | Vasopressin V1a receptor |
---|
Ligand | BDBM50029649 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_214564 (CHEMBL820181) |
---|
Ki | 3.7±n/a nM |
---|
Citation | Williams, PD; Clineschmidt, BV; Erb, JM; Freidinger, RM; Guidotti, MT; Lis, EV; Pawluczyk, JM; Pettibone, DJ; Reiss, DR; Veber, DF 1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist. J Med Chem38:4634-6 (1995) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Vasopressin V1a receptor |
---|
Name: | Vasopressin V1a receptor |
Synonyms: | Avpr1a | V1AR_RAT | VASOPRESSIN V1A | Vasopressin V1 receptor | Vasopressin V1a receptor | Vasopressin receptor |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 47674.81 |
Organism: | RAT |
Description: | VASOPRESSIN V1A AVPR1A RAT::P30560 |
Residue: | 424 |
Sequence: | MSFPRGSQDRSVGNSSPWWPLTTEGSNGSQEAARLGEGDSPLGDVRNEELAKLEIAVLAV
IFVVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQLCWDITYRFRGP
DWLCRVVKHLQVFAMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIATSWVLSFI
LSTPQYFIFSVIEIEVNNGTKTQDCWATFIQPWGTRAYVTWMTSGVFVAPVVVLGTCYGF
ICYHIWRNIRGKTASSRHSKGDKGSGEAVGPFHKGLLVTPCVSSVKSISRAKIRTVKMTF
VIVSAYILCWAPFFIVQMWSVWDENFIWTDSENPSITITALLASLNSCCNPWIYMFFSGH
LLQDCVQSFPCCHSMAQKFAKDDSDSMSRRQTSYSNNRSPTNSTGMWKDSPKSSKSIRFI
PVST
|
|
|
BDBM50029649 |
---|
n/a |
---|
Name | BDBM50029649 |
Synonyms: | 1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-methoxybenzoyl)piperidin-4-yl)-1H-benzo[d][1,3]oxazin-2(4H)-one | 1-{1-[4-(1-Acetyl-piperidin-4-yloxy)-2-methoxy-benzoyl]-piperidin-4-yl}-1,4-dihydro-benzo[d][1,3]oxazin-2-one | CHEMBL24781 | L-371257 |
Type | Small organic molecule |
Emp. Form. | C28H33N3O6 |
Mol. Mass. | 507.5781 |
SMILES | COc1cc(OC2CCN(CC2)C(C)=O)ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2ccccc12 |
Structure |
|